Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/25 16:05 | 3/11/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Kahn Clare | MA | D | P | 10 | 5.34 | 0 | 2 | 169 | 3 | D | |||||||||||||||
2/21/25 17:48 | 2/19/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | P.d | 4,030 | 4.03 | 0 | 1,000 | 25 | 5,035 | I | |||||||||||||||
2/21/25 16:17 | 2/19/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Perceptive Advisors LLC | NY | DT | P | 20,150 | 4.03 | 0 | 5,000 | 72 | 11,907 | I | |||||||||||||||
2/19/25 16:16 | 2/18/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Adage Capital Management, L.P. | MA | T | P | 1,909 | 7.56 | 0 | 253 | 6 | 4,248 | I | |||||||||||||||
6/11/24 14:15 | 6/7/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Kahn Clare | MA | D | P | 8 | 7.67 | 0 | 1 | New | 1 | D | |||||||||||||||
1/12/24 17:15 | 1/11/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Perceptive Advisors LLC | NY | DT | P | 18,861 | 5.53 | 0 | 3,411 | 98 | 6,907 | I | |||||||||||||||
1/12/24 17:01 | 1/11/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | P | 5,000 | 5.53 | 0 | 904 | 27 | 4,302 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |